Artificial and bioartificial liver devices: present and future
Authors:
- A GautierAGA Gautier
- C LegallaisCLC Legallais
Abstract
Liver failure is associated with high morbidity and mortality without transplantation. There are two types of device for temporary support: artificial and bioartificial livers. Artificial livers essentially use non-living components to remove the toxins accumulated during liver failure. Bioartificial livers have bioreactors containing hepatocytes to provide both biotransformation and synthetic liver functions. We review here the operating principles, chemical effects, clinical effects and complications of both types, with specific attention paid to bioartificial systems. Several artificial support systems have FDA marketing authorisation or are CE labelled, but the improvement they provide in terms of patient clinical outcome has not yet been fully demonstrated. At present, different bioartifical systems are being investigated clinically on the basis of their promises and capacity to provide and replace most liver functions. However, important issues such as cost, cell availability, maintenance of cell viability and functionality throughout treatment, and regulatory issues, as well as difficult challenges, including implementing cell-housing devices at the patient’s bedside on an emergency basis, have delayed their appearance in intensive care units and on the market. Bioreactors are, nevertheless, when combined with artificial components, a pragmatic approach for future treatment of liver failure.Keywords
This publication has 65 references indexed in Scilit:
- Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liverJournal of Hepatology, 2008
- Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosisHepatology, 2007
- Acetaminophen‐induced acute liver failureHepatology, 2005
- Molecular Absorbent Recirculating System for the Treatment of Acute Liver Failure in Surgical PatientsJournal of Gastrointestinal Surgery, 2005
- In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separationJournal of Hepatology, 2005
- Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitisJournal of Hepatology, 2005
- Therapy of Intractable Pruritus With MARSTransplantation Proceedings, 2005
- Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: A randomized controlled studyLiver Transplantation, 2004
- Acetaminophen and the U.S. acute liver failure study group: Lowering the risks of hepatic failureHepatology, 2004
- Pilot–Controlled Trial of the Extracorporeal Liver Assist Device in Acute Liver FailureHepatology, 1996